Sex Hormone Receptor Levels in Laryngeal Carcinoma: a Comparison Between Protein and RNA Evaluations

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2008 Feb 5

PMID 18246362

Citations 13

Authors

Chiara Bianchini

Antonio Pastore

Stefano Pelucchi

Elena Torreggiani

Elisabetta Lambertini

Elena Marchesi

Eros Magri

Claudia Frasson

Patrizia Querzoli

Roberta Piva

Affiliations

Soon will be listed here.

Abstract

The larynx is a secondary sex organ, and the hormone dependence of laryngeal carcinomas is considered an interesting matter of speculation. However, while tumors of other secondary sex organs, including the prostate, breast, and endometrium, have been recognized as hormone-dependent cancers, the laryngeal carcinomas are still subject to controversy. In this study, samples from 15 laryngeal carcinomas obtained at the time of surgery were assayed for specific estrogen alpha, progesterone, and androgen receptor expression, both at mRNA and protein levels. Detectable levels of specific estrogen and progesterone receptors, 53.3 and 73.3%, respectively, were found in the tumors. This positive detection by immunohistochemical analysis was higher in tumors than in normal mucosa adjacent to the tumor areas and was correlated with the absence of metastatic lymph nodes. No androgen receptor protein was detected in any sample analyzed, even if quantitative RT-PCR revealed high mRNA levels specific for this receptor. A strict correspondence between protein and mRNA hormone receptor levels was not found. This is in agreement with the transcriptional and protein synthesis mechanisms, and it is also compatible with the complex larynx tumorigenesis.

Citing Articles

Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D and Respond to 24R,25-dihydroxyvitamin D via a Mechanism Dependent on Estrogen Receptor Levels.

Dennis C, Dillon J, Patel P, Cohen D, Halquist M, Pearcy A Cancers (Basel). 2024; 16(9).

PMID: 38730587 PMC: 11083835. DOI: 10.3390/cancers16091635.

Digit ratio (2D:4D), laryngeal cancer and vocal fold leukoplakia.

Pietruszewska W, Morawska J, Manning J, Sitek A, Antoszewski B, Kasielska-Trojan A J Cancer Res Clin Oncol. 2023; 149(11):9349-9359.

PMID: 37211562 PMC: 10374665. DOI: 10.1007/s00432-023-04850-8.

Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma.

Verma A, Schwartz N, Cohen D, Patel V, Nageris B, Bachar G Sci Rep. 2020; 10(1):4227.

PMID: 32144339 PMC: 7060328. DOI: 10.1038/s41598-020-60675-2.

Metabolite Control of Translation by Conserved Peptide uORFs: The Ribosome as a Metabolite Multisensor.

van der Horst S, Filipovska T, Hanson J, Smeekens S Plant Physiol. 2019; 182(1):110-122.

PMID: 31451550 PMC: 6945846. DOI: 10.1104/pp.19.00940.

Novel pipeline identifies new upstream ORFs and non-AUG initiating main ORFs with conserved amino acid sequences in the 5' leader of mRNAs in .

van der Horst S, Snel B, Hanson J, Smeekens S RNA. 2018; 25(3):292-304.

PMID: 30567971 PMC: 6380273. DOI: 10.1261/rna.067983.118.

References

Ferguson B, Hudson W, McCarty Jr K . Sex steroid receptor distribution in the human larynx and laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1987; 113(12):1311-5. DOI: 10.1001/archotol.1987.01860120057008. View

Virolainen E, Tuohimaa P, Aitasalo K, KYTTA J . Steroid hormone receptors in laryngeal carcinoma. Otolaryngol Head Neck Surg. 1986; 94(4):512-7. DOI: 10.1177/019459988609400419. View

Berg N, Colvard D, Neel 3rd H, Weiland L, Spelsberg T . Progesterone receptors in carcinomas of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 1989; 101(5):527-36. DOI: 10.1177/019459988910100503. View

Onesto C, Hannoun-Levi J, Chamorey E, Formento J, Ramaioli A, Pages G . Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance. Br J Cancer. 2006; 94(10):1516-23. PMC: 2361268. DOI: 10.1038/sj.bjc.6603108. View

Solbach C, Roller M, Eckerdt F, Peters S, Knecht R . Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck. BMC Cancer. 2006; 6:242. PMC: 1613251. DOI: 10.1186/1471-2407-6-242. View

Cao W, Zhang L, Liu M, Tang P, Liu Z, Sun B . Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. Hum Pathol. 2007; 38(5):747-52. DOI: 10.1016/j.humpath.2006.11.004. View

Andre K, Schraub S, Mercier M, Bontemps P . Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol. 1995; 31B(5):301-9. DOI: 10.1016/0964-1955(95)00041-0. View

Grenman R, Virolainen E, Shapira A, Carey T . In vitro effects of tamoxifen on UM-SCC head and neck cancer cell lines: correlation with the estrogen and progesterone receptor content. Int J Cancer. 1987; 39(1):77-81. DOI: 10.1002/ijc.2910390114. View

Farshadpour F, Hordijk G, Koole R, Slootweg P . Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis. 2007; 13(2):239-43. DOI: 10.1111/j.1601-0825.2006.01274.x. View

10.

Ogretmenoglu O, Ayas K . Laryngeal carcinoma and estrogen receptor analysis in patients after long-term follow-up. Eur Arch Otorhinolaryngol. 1998; 255(9):457-61. DOI: 10.1007/s004050050099. View

11.

Mattox D, Von Hoff D, McGuire W . Androgen receptors and antiandrogen therapy for laryngeal carcinoma. Arch Otolaryngol. 1984; 110(11):721-4. DOI: 10.1001/archotol.1984.00800370023005. View

12.

Vokes E, Weichselbaum R, Lippman S, Hong W . Head and neck cancer. N Engl J Med. 1993; 328(3):184-94. DOI: 10.1056/NEJM199301213280306. View

13.

Jaber M, Porter S, Gilthorpe M, Bedi R, Scully C . Risk factors for oral epithelial dysplasia--the role of smoking and alcohol. Oral Oncol. 1999; 35(2):151-6. DOI: 10.1016/s1368-8375(98)00106-7. View

14.

Schuller D, Parrish R . Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol. 1984; 110(11):725-7. DOI: 10.1001/archotol.1984.00800370027006. View

15.

KRAJINA Z, Gamulin S . Androgen receptors in normal and neoplastic laryngeal tissue. Arch Otolaryngol Head Neck Surg. 1987; 113(4):411-3. DOI: 10.1001/archotol.1987.01860040073021. View

16.

Toral I, Ciliv G, Gursel B, Ozdem C . Androgen receptors in laryngeal carcinoma. Eur Arch Otorhinolaryngol. 1990; 247(4):244-6. DOI: 10.1007/BF00178995. View

17.

Lambertini E, Penolazzi L, Magaldi S, Giordano S, Del Senno L, Piva R . Transcription factor decoy against promoter C of estrogen receptor alpha gene induces a functional ER alpha protein in breast cancer cells. Breast Cancer Res Treat. 2005; 92(2):125-32. DOI: 10.1007/s10549-005-2413-1. View

18.

Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E . Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res. 2007; 27(1A):335-42. View

19.

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18(3):581-92. DOI: 10.1093/annonc/mdl498. View

20.

Rodrigo J, Dominguez F, Suarez V, Canel M, Secades P, Chiara M . Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007; 133(2):145-50. DOI: 10.1001/archotol.133.2.145. View